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Abstract
Background: Hybrid peripheral nerve sheath tumors (PNSTs) have been recognized recently and were first included in
the 4th edition of World Health Organization (WHO) Classification of Tumors of Soft tissue and Bone, published in 2013.
These tumors show combined features of more than one type of conventional benign peripheral nerve sheath tumors.
The most common combinations are those of schwannoma/perineurioma followed by combinations of neurofibroma/
schwannoma and neurofibroma/perineurioma. A detailed literature review of published cases is presented.
We have discussed the types and etiology, epidemiology and sites of localization, gross and microscopic appearances
and immunohistochemical features of hybrid PNSTs and association of these tumors with tumor syndromes.
Case presentation: We have included five cases which were diagnosed in our department as we believe that publication
of these new cases is relevant for the improved understanding of these specific tumors. Four of our five patients were
males, mean age was 24 years. There was wide variation in the location of these tumors. Mean size of excised tumors was
5.5 cms in the greatest dimensions. Three out of five cases represented hybrid schwannoma/perineurioma histologically.
No significant nuclear atypia, mitotic activity or necrosis seen. All five cases were completely excised. All five patients are
alive and well at the time of writing with no recurrence.
Conclusion: Hybrid PNSTs are distinct tumors and are usually benign. However, rare case reports have described local
recurrence and at least two recent case reports have described malignant transformation in these tumors. Further studies
on large number of cases are required to determine the exact pathogenetic basis of these tumors.
Keywords: Hybrid PNST, Benign, Neurofibroma, Perineurioma, Schwannoma

Background
Hybrid peripheral nerve sheath tumors (PNSTs) are
benign peripheral nerve sheath tumors, which show
combined features of more than one type of benign
PNSTs i.e. neurofibroma, schwannoma and perineurioma.
These tumors have been recognized for some time but
were only recently included officially in the 4th edition of
World Health Organization (WHO) Classification of
Tumors of Soft tissue and Bone and the revised 4th
edition of WHO Classification of Tumors of the
Central Nervous System published in 2013 and 2016
respectively [1, 2].
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The most common types are combinations of Schwannoma/perineurioma, which usually occur sporadically, and
neurofibroma/schwannoma, which are typically associated
with neurofibromatosis (NF) type 1 or 2 or with schwannomatosis. Combinations of neurofibroma/perineurioma
are rare and are usually associated with NF1 [2–5].
Those associated with NF1 carry a risk of malignant
transformation to malignant peripheral nerve sheath
tumors (MPNSTs) [6]. However, exact rates of recurrence and malignant transformation remain largely
unknown owing to extreme rarity of these tumors [7].
Rare case reports have described local recurrence [3, 4, 8].
At least two recent case reports have described malignant
transformation in hybrid PNSTs [8, 9]. Another report,
documenting a recurrent hybrid schwannoma/perineurioma
mentioned the presence of high cellularity and nuclear pleomorphism in both the original and recurrent tumor. The Ki
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67 index was over 10 and 20% in the original and recurrent
tumor respectively. The authors called that tumor a hybrid
schwannoma/perineurioma with low malignant potential.
Criteria for malignancy in perineurioma are not well
defined. WHO mentions hypercellularity, nuclear atypia
with hyperchromasia, and high mitotic rate as the criteria
for malignancy [1]. Hayashi et al. [10] also used the same
criteria plus Ki 67 proportion index greater than 20% to
denote malignancy in perineurioma.
Hybrid PNSTs have been reported in all age groups
but have been most commonly reported in young adults
and so far have not demonstrated any gender predilection.
They show a wide anatomic distribution and can occur
anywhere in the somatic soft tissues, although an occasional case has been reported in the bone. Chow et al. recently reported a case in the femur [11]. Fingers (digits)
are a common site for hybrid schwannoma/perineurioma.
These tumors mostly present as painless masses localized
in the dermis or subcutaneous adipose tissue [3–5]. Hybrid PNSTs rarely arise from spinal or cranial nerves [2].
On gross examination, hybrid PNSTs are usually well-circumscribed nodular lesions nodular, globoid to polypoid in configuration, with firm greyish cut surface. Most
tumors range between 1 to 8 cms in size [4, 8]. Histologically, these tumors demonstrate the morphologic and
immunohistochemical (IHC) features of their constituent components. Most cases described in literature have
two components.
Hybrid schwannoma/perineurioma tumors are circumscribed but usually unencapsulated, have a
perineurioma-like lamellar or storiform, whorling architecture but have a predominantly schwannoma like
cytomorphology being composed of spindle cells with
wavy, tapering nuclei, pale eosinophilic cytoplasm and indistinct cell boundaries. Degenerative changes (similar to
schwannomas) may be seen [2].
Hybrid schwannomas/neurofibromas have a schwannoma like component composed of cellular Antoni A
areas with nuclear palisading forming verocay bodies.
Neurofibroma like areas are composed of cells with wavy
elongated nuclei and scant cytoplasm, fibroblasts and and
a matrix of collagen fibers and mucin positive myxoid material often arranged in a plexiform architeure [3, 5].
The rare hybrid neurofibromas/perineuriomas have
areas of perineuriomatous differentiation along-with
areas of plexiform neurofibroma [10].
On IHC, hybrid schwannomas/perineuriomas demonstrate S100 protein and SOX10 in the schwannomatous
areas, and embryonic membrane antigen (EMA),
Claudin-1 and Glucose Transporter 1 (GLUT-1) in the
perineuriomatous areas. Hybrid schwannomas/neurofibromas demonstrate the S100 protein and SOX10 in
the schwannomatous areas while the neurofibroma
component, being composed of a polymorphic cell
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population, demonstrates positivity for S100, SOX10,
EMA and GLUT1. In hybrid neurofibroma/perineuromas,
neurofibroma component demonstrates positivity as
described above for S100, SOX10, EMA, Claudin 1 and
Glut 1. In perineuriomatous areas, S100 expression is not
seen [3, 4, 10, 12].
Hybrid PNSTs are associated with certain tumor
syndromes, and more than half of hybrid PNSTs with
such associations are multiple. Over 70% patients with
schwannomatosis have single or multiple hybrid neurofibroma/schwannoma tumors. Similarly, over 25%
patients with Neurofibromatosis (NF) 2 and about 90%
patients with NF1 have single or multiple hybrid neurofibroma/schwannoma tumors. Hybrid neurofibroma/
perineurioma tumors occur most commonly in association with NF1 [5, 10].

Case presentation
We report 5 cases of hybrid PNSTs diagnosed in our
department. We searched archive files of the Department
of Pathology and Clinical Laboratory, Aga Khan University
Hospital for cases reported as hybrid peripheral nerve
sheath tumors. The principal authors (NU and ZA)
reviewed the slides of all five cases. The clinical data and
follow-up obtained from medical records, hospital
discharge summary and telephone calls. All available
hematoxylin & eosin (H&E) and IHC stained slides were
reviewed and reassessed.
Out of the five cases, four were diagnosed in males
and one in a female. Ages of the five patients ranged
from 5 to 65 years (Mean: 24 years and Median:
12 years). Of the five cases, three patients were 12 years
or younger in age. Out of all cases, one case each was located in the big toe of left foot, soft tissue of left thigh,
soft tissue of right thigh, soft tissue of the neck region
and retroperitoneum respectively. All patients presented
with swelling or mass at the involved site. In all cases,
tumors were excised and excision specimens were sent
for histopathological examination. Grossly, all tumors
appeared encapsulated and circumscribed; their sizes
varied from 4.0 to 8.5 cm in largest dimension with a
mean size of 5.5 cm. Tumors were nodular to multinodular
in configuration and cut surfaces were firm, gray
white to tan yellow, homogeneous to whorled to myxoidy in appearance. Histopathologically, three cases
represented hybrid schwannoma/perineurioma, 1 case
represented neurofibroma/perineurioma and 1 case
(in the youngest patient) corresponded to schwannoma/neurofibroma (Figs. 1, 2, 3 and 4).
Microscopically, all cases showed fascicles of spindle
cells with elongated, tapering, wavy to plump nuclei. Areas
of nuclear palisading forming verocay bodies were also
seen. Other areas demonstrated a storiform pattern. No
significant mitotic activity was seen in any of the cases
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Fig. 1 a, b Hybrid perineurioma and neurofibroma as distinct areas with perineuromatous component at top (thin arrow) and neurofibroma areas
below it (small thick arrow) (H&E, 40× magnification). c Perineuromatous area is composed of cells with long cytoplasmic processes (H&E, 400×
magnification). d EMA positivity in perineuromatous areas. c, d Neurofibromatous component is composed of spindle cells with wavy nuclei
(100× & 400× magnifications)

Fig. 2 a Low power magnification of same case shown in Fig. 1 to highlight neurofibroma areas (small thick arrow). Perineuromatous focus
shown at right upper corner with thin arrow. b, c Intermediate and higher magnifications of neurofibroma areas. d, e EMA negativity and S100
positivity in neurofibroma areas
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Fig. 3 a to d Case of hybrid perineurioma and schwannoma. Perineuromatous areas shown with thin arrows at periphery and schwannoma
areas shown with thick arrows in center

and no necrosis was identified. Stroma in all cases varied
from loose, edematous, myxoidy to fibrillary and collagenous. Tumors in all cases were completely excised.
IHC staining of the 3 cases of hybrid schwannomas/
perineuriomas showed positivity for S-100 protein in the
schwannomatous areas while EMA and CD34 were
positive in perineuromatous areas. The only case of
neurofibroma/perineurioma also showed positivity for
S100 in the neurofibromatous areas and for EMA and
CD34 in the perineuromatous areas (Fig. 1d). The only
case of schwannoma/neurofibroma was positive for S100
protein in both schwannomatous and neurofibromatous
areas while EMA and CD34 were negative. All five cases
were negative for smooth muscle actin (SMA). The
clinical and pathological features of all five cases are
shown in Table 1. On recent follow up, all five patients

were alive and well with no evidence of residual or
recurrent disease. The clinical and pathological features
of all five cases are shown in Table 2.

Discussion
Hybrid PNSTs were initially described by Feany et al. in
1998 [3] in nine patients, most of which were adults.
The tumor showed components of neurofibroma and
schwannoma in the same tumor. Of those cases, 2 cases
were dermal and subcutaneous, while 5 were subfascial.
They suggested that the presence of schwannoma and
neurofibroma components together in one tumor meant
that in spite of definite clinicopathologic differences, the
two entities were even more closely related than was
earlier thought. Zamecnik in his comment on Feany’s
study called these hybrid tumors “a conceptual

Fig. 4 Immunoprofile of same case illustrated in Fig. 3. a EMA positivity in perineuromatous areas and (b) negativity in schwannoma areas
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Table 1 Clinical and pathological features of hybrid nerve sheath tumors in our series (n = 5)
Serial No

Tumor Type

Age (years)

Gender

Site

Tumor size (cm)

Positive IHC

Negative IHC stains

Year excised

1

Schwannoma/
perineurioma

12

Female

Big Toe (foot)

5.0 × 4.0

S100 EMA
CD34 (focal)

ASMA

2013

2

Schwannoma/
perineurioma

28

Male

Thigh

8.5 × 6.0

S100 EMA
CD34 (focal)

ASMA

2014

3

Schwannoma/
neurofibroma

5

Male

Thigh

5.5 × 4.5

S100

EMA
CD34
ASMA

2014

4

Schwannoma/
perineurioma

12

Male

Neck

5.5 × 4.0

S100 EMA
CD34

Desmin

2014

5

Neurofibroma/
perineurioma

23

Male

Retroperitoneum

8 × 6.5

S100 EMA
CD34

-

2015

challenge” [13]. In 2004, Michal et al. [8] reported 6
hybrid tumors which were combinations of schwannoma
and perineurioma. Out of 6 cases, five occurred on the
digits and 5 were in adult females. Their cases demonstrated the classic IHC stain profile of S100+/CD34,
EMA– in the schwannomatous and the S100– /CD34
and EMA+ in the perineuromatous areas. In 2005,
Kazakov et al. reported 3 extradigital cases, two females
and one male, all in their early fifties who had hybrid
neurofibroma/perineurioma (2 cases) and hybrid
schwannoma/perineurioma (1 case) which were located
in the scapular area, knee and breast [14]. The same year
Murarecu et al. reported a hybrid PNST that had
histological and IHC features of schwannoma and
neurofibroma [15]. In 2006, Emanuel et al. [16] published
a case report of the first ever benign hybrid perineurioma/
schwannoma outside the soft tissue located in the colon.

IHC stain played a major role in differentiating this
colonic tumor from a gastrointestinal stromal tumor
(GIST). In 2008, Shelekhova et al. [17] reported another
case of hybrid neurofibroma/perineurioma in an extradigital site. The fact that these hybrid tumors can arise in
even more unusual sites, which was demonstrated by
Youens et al. [18] by reporting a hybrid neurofibroma/
schwannoma in the orbit of a 51-year-old female. In 2009,
Hornick et al. [4] published a large series of 42 hybrid
schwannoma/perineuriomas. Their cases were almost
equally distributed between males and females, had a
mean age of 38 years, most were subcutaneous or in the
dermis, and were widely distributed in the upper and
lower limbs, head and neck and trunk. One of those cases
was located in the colon. Only one of their cases recurred
following incomplete excision. In 2010, the report of a
hybrid PNST with three components (schwannoma,

Table 2 Comparison of current series with other published series of hybrid peripheral nerve sheath tumors
Serial No. Study

Year published No of cases Tumor types

Age (Mean M/F
age/years)

Location

1

Michal et al. [8]

2004

6

Schwannoma/perineurioma

33

M1/F5

Finger & hand

2

Harder et al. [5]

2012

31

Neurofibroma/ Schwannoma

51

M18/F16 Various nerves including
spinal, ulnar, axillary etc

3

Kacerovska
et al. [10]

2013

5

Perineurioma/ Neurofibroma
(4 cases)

41

M2/F3

Back (2), forearm, abdomen
& thigh 1 case each

35

M2/F8

Subcutis of trunk (n = 3)

Perineurioma/ Neurofibroma
with malignant transformation
(1 case)
4

Yang et al. [13]

2013

10

Schwannoma/perineurioma

Extremities (2), neck, nasal
cavity, sigmoid colon, rectum
& labia majora 1 case each
5

Requena et al.[29] 2013

9

benign cutaneous plexiform
hybrid tumor of perineurioma
and cellular neurothekeoma

6

Current study

5

Schwannoma/neurofibroma (3) 16

2017

Schwannoma/neurofibroma (1)
Neurofibroma/perineurioma (1)

57.6

M5/F4

Upper lip (6), lower lip (3)

M4/F1

Thigh (2), big toe, neck &
retroperitoneum in 1 case each

Ud Din et al. BMC Cancer (2017) 17:349

neurofibroma and perineurioma, which were distinct morphologically and on IHC staining examination) in the
nasopharynx demonstrated that hybrid PNSTs can have
more than two components and that pathologists need to
be aware of the possibility of hybrid tumors rarely occurring outside the somatic soft tissues [19].
In 2011, Hayes and O′ Sullivan reported a hybrid benign
PNST in an inguinal lymph node of a 13-year-old male,
demonstrating the importance of accurate diagnosis because spindle cell lesions in lymph nodes normally raise the
suspicion of a metastatic tumor [20]. Similarly, in 2011,
Agaimy and Michal [21] reported 2 cases of hybrid
Schwannoma/perineurioma in the stomach and appendix
which were both detected incidentally during surgery which
were performed for suspected gastric GIST and acute
appendicitis, respectively. The authors proved that such
gastrointestinal hybrid PNSTs are histologically and
immunohistochemically distinct from gastrointestinal
schwannomas. The same year, Pusiol et al. published a
paper demonstrating that the routine use of IHC stains may
increase the frequency of hybrid PNSTs [22]. To our knowledge, malignant transformation of hybrid PNST was first
reported by Rekhi and Jambhekar in 2011 in a young male
with a mass in the right thigh who had a hybrid schwannoma/perineurioma with transformation into a malignant
peripheral nerve sheath tumor (MPNST) [9]. Hybrid
schwannoma/perineurioma has also been reported to occur
following radiation [23]. In 2012, Park et al. [24] reported
the first hybrid PNST from Korea, a hybrid perineurioma/
schwannoma in the posterior mediastinum of a 53-year-old
male. In 2012, Harder et al. [5] demonstrated that hybrid
neurofibroma/schwannoma is a common tumor in patients
with schwannomatosis and neurofibromatosis.
Also in 2012, Lang et al. [25] published a report of an
even rarer occurrence of multiple, painful hybrid neurofibroma/schwannomas in the scalp, left axilla, left
femoral nerve and both sciatic nerves of a 28-year-old
female with no clinical features of NF type 2 or schwannomatosis and negative genetic testing for NF type 1. In
2013, a study of 10 cases of hybrid schwannoma/perineuriomas from China was published which demonstrated a marked female predominance, and a mean age
of 35 years. Of 10 cases, seven were located in the
subcutaneous tissues of trunk, extremities and neck
while 3 cases were located in the nasal cavity, sigmoid
and rectum [12]. Hybrid PNSTs when occurring in unusual sites such as gastrointestinal tract can be extremely
difficult to classify and diagnostically very challenging
[26]. A report by Wang et al. [27] in 2013 showed that
congenital melanocytic nevus might show neural differentiation with histopathologic features of hybrid schwannoma/perineurioma. The patient was a 36-year-old male
with a black tumor on his arm since birth. Also in 2013,
Las Heras et al. [28] reported the first ever case of a
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hybrid perineurioma/schwannoma in a cranial nerve.
The patient was a 24-year-old female with an internal
auditory canal mass. The same year, Requena et al. [29]
published a series of 9 hybrid PNSTs, all located on the
lips and histologically showing distinct features of perineurioma and cellular neurothekeoma. Hayashi et al.
reported multifocal intradural tumors at T11/12 and L1
in a 63-year-old-male. All were histologically consistent
with hybrid schwannoma/perineurioma, had features of
high cellularity, nuclear atypia and raised proliferative
index which recurred five months after surgical resection
as an intraneural perineurioma, showing mitotic activity
and proliferative index even higher than that seen in the
primary hybrid tumors [30]. Following Requena et al.
[29] in 2013, Yamada et al. [31] reported a hybrid
perineurioma and cellular neurothekeoma arising in the
nose (unlike Requena’s nine cases, all of which were
located in the lips). In 2013, which was indeed a very dynamic year for publication of reports and series of hybrid PNSTs, Kacerovska et al. [10] published a series of
five cases occurring in the setting of NF Type 1. Out of
those cases, one showed malignant change in the neurofibromatous component. Interestingly, three (60%)
patients were members of a single family with a tragic
history of various malignant neoplasms. Another hybrid
perinurioma/neurofibroma in a patient with NF Type 1
was reported by Inatomi et al. in 2014 [32]. Also in
2014, Soria-Cespedes et al. [33] reported the first hybrid
schwannoma/perineurioma in the pleura while Chow et
al. reported a hybrid PNST in the femur, which was associated with a secondary aneurysmal bone cyst and resulted in a pathological fracture [11]. Murray et al. [34]
reported a case of multiple neurofibroma/schwannoma
hybrid tumors arising from the facial nerves in early
2015. In April 2015, Linos et al. reported a case of benign cutaneous biphasic hybrid tumor of perineurioma
and cellular neurothekeoma (BCPHTPCN), a recently
described entity that presents in the perioral area as a
solitary popular lesion and microscopically demonstrates
a plexiform pattern. However, their case involved the
ankle as a firm, fresh colored nodule and did not show a
plexiform pattern. They argued that BCPHTPCNs can
grow in a non-plexiform pattern and suggested the alternate term ‘Benign cutaneous biphasic hybrid tumor of
perineurioma and cellular neurothekeoma’ for these rare
lesions. They also suggested that these tumors could
arise outside the head and neck region [35]. In late 2015,
Panda and Reena [36] reported an intraneural hybrid
neurofibroma/schwannoma in the scalp of a 30-year-old
male, while Taubenslag et al. [7] reported a hybrid
neurofibroma/schwannoma arising from the supraorbital
nerve. Also in 2015, McLaughlin et al. published the report of a hybrid PNST with three components (schwannoma/perineurioma/neurofibroma morphology), an even
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rarer occurrence within these extremely rare tumors.
This tumor presented as a slowly enlarging, painful nodule in the upper thoracic region. It attained a size of
nearly 8 cm in largest diameter over a course of five
years [37].
Even today the exact pathogenetic basis of dual (or
even triple) differentiation in hybrid PNSTs is poorly
understood and whether such hybrid differentiation
results from a clonal genetic alteration or from a localized
change in the microenvironment is not known [3, 4].
Questions have even been raised about whether hybrid
PNSTs really are a distinct entity or not. Very recently,
Stahn et al. [38] performed a molecular analysis of 22
hybrid neurofibromas/schwannomas using immunohistochemistry, quantitative RT-PCR, array comparative
genomic hybridization and cultured Schwann cells. They
detected monosomy 22 (loss of chromosome 22) in 44%
of their cases. Their investigations also indicated involvement of α-T-catenin/CTNNA3 in the biology of PNSTs.
Published case series are summarized in Table 2.

Conclusion
In conclusion, we are of the opinion that PNSTs with
well-defined hybrid features are indeed distinct entities as demonstrated not only by their hybrid
morphology, but also by their distinct hybrid IHC
features. More recently, advances in molecular techniques have further documented the existence of
hybrid PNSTs as distinct tumor entities. The status of
hybrid PNSTs as distinct entities has been recognized
by the WHO and included in the 4th edition of the
WHO classification of tumors of soft tissue and bone.
However, further studies are required to determine
the status of hybrid PNSTs as distinct entities and to
determine the exact pathogenetic basis of hybrid differentiation in PNSTs.
All five of our cases demonstrated the classical clinical,
microscopic and IHC features of hybrid PNSTs. One of
our cases was located in the retroperitoneum, an
extremely rare location of hybrid PNSTs. None of the
tumors has recurred to date and no malignant change
was detected in any of the cases.
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